Industry Upset as Germany Classifies CBD as a Novel Food

November 19, 2019 16:00:00

The hemp sector in Germany has been left in a bind after the country’s federal government recently confirmed that cannabidiol (CBD) is to be classified as a novel food. Entities interested in selling CBD products will have to apply for marketing authorization before sending their products into the market, a tedious and expensive process.

A novel food is a type of food that doesn’t have much history of consumption or is produced through previously unused methods. European Union (EU) regulations state that “any food that was not consumed significantly before March 1997 is considered a novel food. The category covers new foods, food from new sources, new substances used in…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.